BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2474211)

  • 1. Polyclonal rabbit gamma globulins against a human cytotoxic CD4 T cell clone. II. Use in prevention of rejection in kidney transplantation: a pilot study.
    Hourmant M; Babinet F; Cantarovich D; Latour M; Carcagne J; Vie H; Bonneville M; Moreau JF; Carosella E; Bignon JD
    Transplantation; 1989 Aug; 48(2):260-3. PubMed ID: 2474211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal rabbit gamma globulins against a human cytotoxic CD4+ T cell clone. I. Clone characteristics and antiblast globulin preparation.
    Bonneville M; Carcagne J; Vie H; Moreau JF; Chevalier S; Latour M; Carosella E; Soulillou JP
    Transplantation; 1989 Aug; 48(2):253-60. PubMed ID: 2474210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of OKT3 with ALG for prophylaxis for patients with acute renal failure after cadaveric renal transplantation.
    Steinmuller DR; Hayes JM; Novick AC; Streem SB; Hodge E; Slavis S; Martinez A; Graneto D; Pearce G
    Transplantation; 1991 Jul; 52(1):67-71. PubMed ID: 1677502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
    Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
    Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.
    Djamali A; Turc-Baron C; Portales P; Leverson G; Chong G; Clot J; Mourad G
    Transplantation; 2000 Mar; 69(5):799-805. PubMed ID: 10755529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rabbit globulin anti-CD4+ lymphocyte clone derived from a rejected kidney in the prevention of rejection in kidney transplantation: a pilot study.
    Hourmant M; Babinet F; Cantarovich D; Latour M; Carcagne J; ViƩ H; Bonneville M; Moreau JF; Carosella E; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1587-8. PubMed ID: 2652516
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].
    Kiparski Av; Frei D; Fierz W; Frei G; Uhlschmid G; Largiader F; Binswanger U
    Klin Wochenschr; 1990 Apr; 68(8):408-14. PubMed ID: 1971857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.
    Hourmant M; Le Mauff B; Cantarovich D; Dantal J; Baatard R; Denis M; Jacques Y; Karam G; Soulillou JP
    Transplantation; 1994 Jan; 57(2):204-7. PubMed ID: 8310508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients.
    Peddi VR; Bryant M; Roy-Chaudhury P; Woodle ES; First MR
    Transplantation; 2002 May; 73(9):1514-8. PubMed ID: 12023634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI; Cohen D; Stegall MD; Hardy MA
    Transplantation; 1990 Feb; 49(2):321-7. PubMed ID: 2137654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale preparation of polyclonal rabbit gamma globulins against a human cytotoxic CD4+ T-cell clone.
    Bonneville M; Carcagne J; Vie H; Moreau JF; Chevalier S; Latour M; Carosella E; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):970-2. PubMed ID: 2468231
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression.
    Thomas J; Alqaisi M; Cunningham P; Carver M; Rebellato L; Gross U; Patselas T; Araneda D; Thomas F
    Transplantation; 1992 Feb; 53(2):247-58. PubMed ID: 1531393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocytic molecules implicated in rosette phenomenon. Differential effect of antilymphocyte serum on T (CD2+E2+) and B (CD2-E2+) lymphocytes].
    Ticchioni M; Bernard-Pomier G; Cassuto-Viguier E; Zoccola D; Allieri-Rosenthal MA; Vivinus M; Bernard A
    Therapie; 1992; 47(4):293-6. PubMed ID: 1494790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin.
    Kormos RL; Armitage JM; Dummer JS; Miyamoto Y; Griffith BP; Hardesty RL
    Transplantation; 1990 Feb; 49(2):306-11. PubMed ID: 2137653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.